0001562180-19-005302.txt : 20191101 0001562180-19-005302.hdr.sgml : 20191101 20191101162253 ACCESSION NUMBER: 0001562180-19-005302 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190211 FILED AS OF DATE: 20191101 DATE AS OF CHANGE: 20191101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Di Donato Brian CENTRAL INDEX KEY: 0001766498 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 191187089 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 3/A 1 primarydocument.xml PRIMARY DOCUMENT X0206 3/A 2019-02-11 2019-02-11 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001766498 Di Donato Brian C/O ACHILLION PHARMACEUTICALS, INC. 1777 SENTRY PARKWAY W, BLDG 14, STE 200 BLUE BELL PA 19422 false true false false SVP, Chief Financial Officer Stock Options (Right to buy) 2.56 2028-08-07 Common Stock 200000.00 D This option was granted on August 7, 2018 and vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. This Form 3/A amends and restates the Form 3 filed by the reporting person on February 11, 2019. /s/ Brian Di Donato 2019-11-01